T TAYLOR PHARMACEUTICALS AN AKORN COMPANY Trademark

Trademark Overview

On Friday, October 16, 1998, a trademark application was filed for T TAYLOR PHARMACEUTICALS AN AKORN COMPANY with the United States Patent and Trademark Office. The USPTO has given the T TAYLOR PHARMACEUTICALS AN AKORN COMPANY trademark a serial number of 75572570. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 5, 2021. This trademark is owned by Taylor Pharmaceuticals. The T TAYLOR PHARMACEUTICALS AN AKORN COMPANY trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceuticals, namely alfentanil injection, fentanyl injection, sufentanil injection, droperidol injection for use in the induction of anesthesia; and, namely dimercaprol injection, caffeine and sodium benzoate injection, cyanide antidote package, dehydrated alcohol injection, methylene blue injection, papaverine injection, physostigmine injection for use as antidotes; and, namely indigotindisulfonate injection for use as a diagnostic; and, namely ephedrine injection for use in the treatment of allergic disorders; and, namely gold sodium thiomalate injection for use the treatment of rheumatoid disease
t taylor pharmaceuticals an akorn company

General Information

Serial Number75572570
Word MarkT TAYLOR PHARMACEUTICALS AN AKORN COMPANY
Filing DateFriday, October 16, 1998
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 5, 2021
Registration Number2340300
Registration DateTuesday, April 11, 2000
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 18, 2000

Trademark Statements

Goods and ServicesInjectable pharmaceuticals, namely alfentanil injection, fentanyl injection, sufentanil injection, droperidol injection for use in the induction of anesthesia; and, namely dimercaprol injection, caffeine and sodium benzoate injection, cyanide antidote package, dehydrated alcohol injection, methylene blue injection, papaverine injection, physostigmine injection for use as antidotes; and, namely indigotindisulfonate injection for use as a diagnostic; and, namely ephedrine injection for use in the treatment of allergic disorders; and, namely gold sodium thiomalate injection for use the treatment of rheumatoid disease
Disclaimer with Predetermined Text"PHARMACEUTICALS" AND "COMPANY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateWednesday, July 15, 1998
First Use In Commerce DateWednesday, July 15, 1998

Trademark Owner History

Party NameAKORN OPERATING COMPANY LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressLAKE FOREST, IL 60045
Party NameAKORN, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameTaylor Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDecatur, IL 62522
Party NameTaylor Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDecatur, IL 62522
Party NameTaylor Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDecatur, IL 62522

Trademark Events

Event DateEvent Description
Wednesday, July 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 10, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 5, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, September 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 1, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 14, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 10, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 2, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 18, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 21, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, April 11, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 13, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 13, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 23, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 16, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 16, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 20, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, April 20, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, April 20, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 13, 2010TEAS SECTION 8 & 9 RECEIVED
Tuesday, August 4, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 4, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 15, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 20, 2006RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15
Monday, November 20, 2006PAPER RECEIVED
Friday, August 18, 2006POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sunday, June 25, 2006ASSIGNED TO PARALEGAL
Friday, April 7, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, April 7, 2006TEAS SECTION 8 & 15 RECEIVED
Friday, April 7, 2006CASE FILE IN TICRS
Tuesday, April 11, 2000REGISTERED-PRINCIPAL REGISTER
Tuesday, January 18, 2000PUBLISHED FOR OPPOSITION
Friday, December 17, 1999NOTICE OF PUBLICATION
Tuesday, October 19, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 14, 1999EXAMINER'S AMENDMENT MAILED
Wednesday, August 25, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 30, 1999NON-FINAL ACTION MAILED
Friday, May 28, 1999NON-FINAL ACTION MAILED
Wednesday, May 12, 1999ASSIGNED TO EXAMINER

Related Keywords

company akorn pharmaceuticals taylor injection namely sodium treatment indigotindisulfonate antidotes physostigmine papaverine diagnostic blue